LONDON – AstraZeneca says it delivered about 68 million doses of its COVID-19 vaccine during the first three months of 2021 after the shot became one of the first approved for widespread use.
The Anglo-Swedish drugmaker on Friday reported $275 million in revenue from sales of the vaccine, or the equivalent of $4.04 per dose.
AstraZeneca has pledged that it will deliver the vaccine on a non-profit basis as long as the pandemic lasts. [TRENDING: Thousands skipping 2nd vaccine dose | This K-9 is stopping child abuse.
Here’s how | Florida legislature passes controversial vote-by-mail bill] The company said 30 million doses of the vaccine went to the European Union, 26 million to the U.K., 7 million to Gavi, an alliance that secures vaccines for